Cutaneous manifestations of zinc deficiency during treatment with anticonvulsants.
D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D010672:Phenytoin / Q000009:adverse effects; D012871:Skin Diseases / Q000139:chemically induced* / Q000378:metabolism; D014635:Valproic Acid / Q000009:adverse effects; D015032:Zinc / Q000172:deficiency*
D000927:Anticonvulsants; D014635:Valproic Acid; D010672:Phenytoin; D015032:Zinc